Updated: A shortage of amoxicillin is now being reported by several manufacturers
Only a few weeks after the FDA recognized a shortage of Adderall, another crucial drug is in low supply, this time the antibiotic amoxicillin.
According to the American Society of Health System Pharmacists’ (AHSP) drug shortage list, three manufacturers are posting shortages of the oral version of the drug. The list includes Hikma Pharmaceuticals, Teva and Sandoz, which are reporting low supplies of multiple dosage amounts. The companies did not post a reason for the shortages.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,600+ biopharma pros reading Endpoints daily — and it's free.